The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
FDA held no advisory meeting on antiviral, and Europan Union signed contract without knowing of failed trial
Related Articles
Plans to expand African vaccine production face steep hurdles
Moderna’s pause on Kenya project highlights difficulties in creating a competitive vaccine sector on the continent
Young toads are teaching Australian lizards to avoid deadly snacks
Massive trial shows monitor lizards will learn to avoid toxic and invasive adult toads after tasting less dangerous juveniles
Africa intensifies battle against mpox as ‘alarming’ outbreaks continue
New variant identified in Congolese mining town renews worries about global spread
Universities should experiment to improve caregiver support, U.S. National Academies says
New report recommends paid leave, flexible work policies, and changes in academic culture
Watch a beetle larva ambush snails from below, dragging them to their demise
Immature click beetles on the Ryukyu Islands of southwestern Japan display a behavior never before observed in their kind
Messenger RNA technology shows first promise against a rare and deadly disease
“Milestone” Moderna trial finds fewer medical crises in some people with metabolic disorder after RNA infusions
These gars are the ultimate ‘living fossils’
Fish’s genomes are so static that groups whose last common ancestor lived during the time of the dinosaurs can produce fertile hybrids today
Pregnancy may increase biological age by 2 years—though some people end up ‘younger’
Body’s cells appear to age faster during pregnancy, but they might recover—and even thrive—in the months after birth
Modern Blackfoot people descend from an ancient ice age lineage
A new study of historic and modern genomes may help tribes protect ancestral lands and water rights
This pterosaur supported its giant neck with bones built like bicycle wheels
The internal structure of vertebrae made azhdarchid necks strong but light